ACORDA THERAPEUTICS (ACOR) Covered Calls

ACORDA THERAPEUTICS covered calls Acorda Therapeutics, Inc. is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and disorders of the central nervous system.

You can sell covered calls on ACORDA THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ACOR (prices last updated Mon 4:16 PM ET):

ACORDA THERAPEUTICS (ACOR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
19.13 -0.65 15.50 21.50 346K - 0.9B
Covered Calls For ACORDA THERAPEUTICS (ACOR)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 19 1.60 19.90 -4.5% -49.8%
Jan 18 19 3.00 18.50 2.7% 16.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system. The company's two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. Acorda Therapeutics was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.